Corey Mahan

We help healthtech startups secure high-value commercial partnerships with leading medtech and pharma players, and connect with strategic investors who recognize the potential – driving premium valuations from seed stage onwards. Go-to-market 80%+ of our cases receive 5-10x valuation, because of our methods that fastrack international sales of innovative health tech solutions. We have led international sales, built OEM partnerships, negotiated distributor agreements, and helped companies grow from early traction to acquisition. Capital network With the improved valuation from our go-to-market methods, we help startups with faster and better access to qualified investors. Based in Switzerland, a global hotspot for health tech innovation and capital, we facilitate faster access to our vetted investor network. Book a call with us.